Kallikrein 9 antibody (Middle Region)
Quick Overview for Kallikrein 9 antibody (Middle Region) (ABIN953103)
Target
See all Kallikrein 9 (KLK9) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 81-111, Middle Region
-
Specificity
- This antibody recognizes Human KLK19 / Kallikrein-19 (Center).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 81-111 amino acids from the Central region of Human KLK9 / Kallikrein-9
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Kallikrein 9 (KLK9)
-
Alternative Name
- KLK9 / Kallikrein-9
-
Background
- The protein encoded by this gene is a kallikrein-related serine protease. This gene is activated by steroid hormones in a human breast cancer cell line, making it a good marker for cancer detection. The encoded protein is found primarily in the cytoplasm.Synonyms: KLK-L3, KLKL3, Kallikrein-like protein 3
-
Molecular Weight
- 27513 Da
-
Gene ID
- 284366
-
NCBI Accession
- NP_036447
-
Pathways
- Complement System
Target
-